Navigation Links
Mundipharma's Commitment to Accelerated Business Growth Supported by Appointment of Paul Medeiros to Head Its Corporate and Business Development
Date:3/14/2012

CAMBRIDGE, England, March 14, 2012 /PRNewswire/ -- Mundipharma International has appointed Paul Medeiros to head its corporate and business development operations. In this position, Mr. Medeiros will join the Executive Leadership Team and play a critical role in extending and expanding avenues for corporate growth within Mundipharma's European independent associated companies, many of which are growing faster than any other midsized pharmaceutical companies in the market.

Mr. Medeiros brings over 19 years of experience in biopharmaceutical business development and commercialization and a significant track record of success in technology acquisitions, in- and out-licensing, and strategic alliance development across a therapeutic areas. He most recently served as Senior Vice President and Chief Business Officer at AVI BioPharma, a technology-innovating developer of RNA-based therapeutics for rare diseases. In that role, he was responsible for all business development and licensing activity, establishment of academic and commercial research collaborations, product portfolio planning and corporate strategy development. At AVI, he was instrumental in obtaining over $300 million in non-dilutive collaboration funding for the company. Previously, Mr. Medeiros served as Vice President, Global Licensing and Strategic Alliances for Schering-Plough, where he led worldwide product licensing and strategic partnering initiatives in specialist product categories. Mr. Medeiros began his biopharmaceutical career at Merck & Company, where he held positions in field sales, new product planning and worldwide marketing.

"Paul's deep experience and network in the pharma industry, combined with his entrepreneurial mind-set and nuanced understanding of the business, will be essential for Mundipharma's continued growth," said Antony Mattessich, Regional Director, Mundipharma Europe. "We are thrilled to add his energy and expertise to our team, and we look forward to
'/>"/>

SOURCE Mundipharma International Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sigma® Life Science Obtains Global License for Kyoto Universitys iPS Cell Patent Portfolio, Deepens Commitment to Drug Discovery and ADME/Toxicology
2. Aptuit Completes Sale of CTS to Catalent; Reinforces Commitment to Scientific Excellence and Most Comprehensive Early to Mid-Phase Development Capability
3. PA Governor Corbett Visits Future Site of Endo Pharmaceuticals HQ; Praises Company for its Continued Commitment to Pennsylvania
4. Chile, U.S. Strengthen Ties, Commitment to Quality Medicines
5. Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio
6. Philips Enters North American Mammography Market, Underscoring its Global Commitment to Womens Health Care
7. UCB Proudly Reinforces Long-Standing Commitment to Patients and Physicians at American College of Gastroenterology 2011 Annual Scientific Meeting
8. Philips Teams up With Integrated Oncology Network, Reinforcing Its Commitment to the Future of Cancer Care
9. Medical Alarm Concepts Receives Growth Capital Injection and Commitment for Future Funding
10. Commonwealth Welcomes Global Commitment to Combat Non-Communicable Diseases
11. BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)...  EnteroMedics Inc. (NASDAQ: ETRM ), a developer ... treat obesity, metabolic diseases, and other gastrointestinal disorders, announced ... 40,229,886 units. Each unit consists of one share of ... purchase one share of common stock, and 0.50 of ... common stock, at a purchase price of $0.87 per ...
(Date:6/30/2015)... Calif. and COPENHAGEN, Denmark ... Inc. , a global leader in clinical and commercial ... today that, as part of its global manufacturing capacity ... North American manufacturing facility in Bothell, Washington ... 6Pack™ facility.  The Bioreactor 6Pack™ configuration consists of six ...
(Date:6/29/2015)... Mordor Intelligence presents their Global Pharmaceutical Packaging Market ... Metal) - ByType of Packaging (Ampules, Blister Packs, Bottles, Canisters, ... By Geographical Region ( North America , ... Latin America , Middle East ... Industry Value Chain Analysis, Porter,s 5 Force Analysis, Drivers, Restraints, ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3CMC Biologics Expands GMP Manufacturing Capacity in the United States 2CMC Biologics Expands GMP Manufacturing Capacity in the United States 3Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
... Cepheid (Nasdaq: CPHD ) today announced that ... Vice President of Infectious Disease Research and Development, reporting ... offers an impressive menu of eleven highly regarded Xpert® ... aggressively to extend our leadership with next-generation products, including ...
... 2011 In a recent announcement by Neurelis, ... positive clinical results in a Phase I pharmacokinetic ... at Particle Sciences.  In the Phase 1 clinical ... that reported in the literature for Diastat® (rectal ...
Cached Medicine Technology:Cepheid Appoints Vice President of Infectious Disease Research & Development 2Cepheid Appoints Vice President of Infectious Disease Research & Development 3Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam) 2
(Date:6/30/2015)... ... June 30, 2015 , ... ... official ready-to-drink sponsor of two leading organizations dedicated to raising worldwide awareness of ... , I AM ADAPTIVE™ is now the official charity of FitAID. I AM ...
(Date:6/30/2015)... ... ... The United Nations Foundation’s Universal Access Project, in partnership with Planned Parenthood ... contest today. Why We Care Youth serves as a platform for young people living ... meant to them, and why U.S. policymakers should care about expanding access around the ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... device market research, has launched a new reimbursement insurance policy tracking and analysis ... to receive US insurance policy and rate updates in real-time from hundreds of ...
(Date:6/30/2015)... ... June 30, 2015 , ... Tulika Ranjan, MD, a prominent ... (AHN) as Director of its Adult Neuro-Oncology program. , Dr. ... metastases, leptomeningeal disease and the neurological complications of cancer. She has special ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... national testosterone claims alleging heart attack and stroke incidents are linked to testosterone ... Day. The Case Management Conference is scheduled for July 9, 2015, according to ...
Breaking Medicine News(10 mins):Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:iData Research Introduces New Medical Insurance Reimbursement Policy & Rate Tracker Subscription Service 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 2Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 4
... who suffer a heart attack or severe chest pain today are ... their counterparts// even a few years ago, according to a new ... has shown a significant drop in the rate of heart failure ... ,The study finds that the change occurred at the ...
... are used to shock the heart back to normal are found ... of five fails to work after just ten years. On research ... , The wire or the lead sometimes shocked the ... abnormally or completely stopped. ,Many a times it causes ...
... to a Group of Ministers (GOM) though no timeframe has ... ,The policy envisages ways to make available cheaper ... to promote the production and marketing of generic drugs in ... and fertilisers and parliamentary affairs. ,The policy ...
... of marijuana on humans has come to light. //It ... hallucinations and paranoid delusions, it has been found. ... or CBD, made people more relaxed. But even small ... psychotic symptoms in people, including hallucinations and paranoid delusions, ...
... WA) has agreed to pay the US $10.5 millon ... of the anti-cancer prescription drug Trisenox, the US Justice ... the government's complaint, CTI promoted the drug for various ... Drug Administration (FDA). ,The alleged "off-label" uses ...
... After hurricane Katrina what can be worse? Apparently, the region ... healthcare// , mainly due to the shortage of practicing doctors. ... to pick up the threads of their life, post Katrina. ... met a watery end. Most hospitals are seen managing huge ...
Cached Medicine News:Health News:Good News for Sufferers of Heart Attack, Chest Pain 2Health News:Good News for Sufferers of Heart Attack, Chest Pain 3Health News:Good News for Sufferers of Heart Attack, Chest Pain 4Health News:Marijuana can Trigger Psychotic Symptoms, New Study Finds 2Health News:CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG 2
... The table-mounted hip ... hands-free exposure for total ... to accommodate individual surgeon ... of any size. Hand-held ...
... gelatinase-associated lipocalin, lipocalin-2) is a new early ... renal failure with a >90% positive predictive ... urine, as early as 2 hours after ... diagnostic marker for acute renal failure. ,Quantitative ...
... "Beautiful tissue is how one neurosurgeon describes ... Needle. By "beautiful he means a,cleaner cut ... are,functions of the needles optimized vacuum and ... captive locking thumb nut holds vacuum,in the ...
CVC 123 is an assayed quality control material used for confirming the calibration and linearity of blood gas, electrolyte, and metabolite instrumentation....
Medicine Products: